David Clair | Senior Director, IR and Corporate Development |
Chuck Kummeth | CEO |
Jim Hippel | CFO |
Puneet Souda | SVB Leerink |
Dan Arias | Stifel |
Jacob Johnson | Stephens Inc. |
Patrick Donnelly | Citi |
Catherine Schulte | Baird |
Alex Nowak | Craig-Hallum Capital Group |
Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2022. [Operator Instructions] I would now like to turn the call over to David Clair, Bio-Techne's Senior Director, Investor Relations and Corporate Development.
Good morning, and thank you for joining us.
On the call with me this morning are: Chuck Kummeth, Chief Executive Officer; and Jim Hippel, Chief Financial Officer of Bio-Techne.
Before we begin, let me briefly cover our safe harbor statement.